The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The half-life of c- myc mRNA is regulated when cells change their growth rates or differentiate. Two regions within c- myc mRNA determine its short half-life. One is in the 3'-untranslated region, the other is in the coding region. A cytoplasmic protein, the coding region determinant-binding protein (CRD-BP), binds in vitro to the c- myc coding region instability determinant. We have proposed that the CRD-BP, when bound to the mRNA, shields the mRNA from endonucleolytic attack and thereby prolongs the mRNA half-life. Here we report the cloning and further characterization of the mouse CRD-BP, a 577 amino acid protein containing four hnRNP K-homology domains, two RNP domains, an RGG RNA-binding domain and nuclear import and export signals. The CRD-BP is closely related to the chicken beta-actin zipcode-binding protein and is similar to three other proteins, one of which is overexpressed in some human cancers. Recombinant mouse CRD-BP binds specifically to c- myc CRD RNA in vitro and reacts with antibody against human CRD-BP. Most of the CRD-BP in the cell is cytoplasmic and co-sediments with ribosomal subunits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.
Siomi, H., Siomi, M. C., Nussbaum, R. L., & Dreyfuss, G. (1993) · Cell · doi:10.1016/0092-8674(93)90420-u · Cited by 641
Eberhart, D. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.8.1083 · Cited by 390
Siomi, M. C., Zhang, Y., Siomi, H., & Dreyfuss, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3825 · Cited by 271
Cited by
Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation
Huang, H., Weng, H., Sun, W., Qin, X., Shi, H., Wu, H., Zhao, B. S., Mesquita, A., Liu, C., Yuan, C. L., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0045-z · Cited by 2,997
Mayr, C., & Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.06.016 · Cited by 1,613
“…that is overexpressed in a variety of human cancers, including those of the breast, lung and colon, where it potentially plays a role in stabilizing several target mRNAs, including c-myc, b-catenin and b-TrCP1 (Ross et al., 1997; Doyle et al., 1998; Nielsen et al., 1999; Noubissi et al., 2006).”
RNA N6-methyladenosine modification in cancers: current status and perspectives
Deng, X., Su, R., Weng, H., Huang, H., Li, Z., & Chen, J. (2018) · Cell Research · doi:10.1038/s41422-018-0034-6 · Cited by 845
Eukaryotic mRNPs May Represent Posttranscriptional Operons
Keene, J. D., & Tenenbaum, S. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00559-2 · Cited by 460
Cheng, M., Sheng, L., Gao, Q., Xiong, Q., Zhang, H., Wu, M., Liang, Y., Zhu, F., Zhang, Y., Zhang, X., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0683-z · Cited by 403
RNA‐binding IMPs promote cell adhesion and invadopodia formation
Vikesaa, J., Hansen, T. V., Jønson, L., Borup, R., Wewer, U. M., Christiansen, J., & Nielsen, F. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601039 · Cited by 341
Degrauwe, N., Suvà, M.-L., Janiszewska, M., Riggi, N., & Stamenkovic, I. (2016) · Genes & Development · doi:10.1101/gad.287540.116 · Cited by 324
“IMP1 (a ZBP1 ortholog) was identified as a protein involved in MYC mRNA stabilization (Doyle et al. 1998).”
BackgroundAutoantibodies to tumor‐associated antigens: reporters from the immune system
Tan, E. M., & Zhang, J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00611.x · Cited by 309
Farina, K. L., Hüttelmaier, S., Musunuru, K., Darnell, R., & Singer, R. H. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200206003 · Cited by 271
Hansen, T. V. O., Hammer, N. A., Nielsen, J., Madsen, M., Dalbaeck, C., Wewer, U. M., Christiansen, J., & Nielsen, F. C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4448-4464.2004 · Cited by 251
“4448 on A pril 30, 2019 by guest http://m cb.asm .org/ D ow nloaded from Finally, mouse CRD-BP, which binds to a 250-nucleotide element in the 3 end of the coding region of c-myc mRNA stabilizes the messenger (18, 54), and it has been proposed that CRD-BP protects the transcript from an endonuclease.”
BackgroundVICKZ proteins: a multi‐talented family of regulatory RNA‐binding proteins
Yisraeli, J. K. (2005) · Biology of the Cell · doi:10.1042/bc20040151 · Cited by 231
“Human c-myc hCRD-BP, mCRD-BP (hVICKZ1, mVICKZ1) (Doyle et al., 1998)”
BackgroundInfluentialmRNA Stability and the Control of Gene Expression: Implications for Human Disease
Hollams, E. M., Giles, K. M., Thomson, A. M., & Leedman, P. J. (2002) · Neurochemical Research · doi:10.1023/a:1020992418511 · Cited by 212
The c‐myc Promoter: Still MysterY and Challenge
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99004-1 · Cited by 211
Hoo, L. S., Zhang, J. Y., & Chan, E. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205625 · Cited by 201
“The human IMPs have high sequence similarity with other RNA binding proteins such as the Xenopus Vg1RBP/Vera protein (Deshler et al., 1998; Havin et al., 1998), the chicken zipcode-binding protein (ZBP-1) (Ross et al., 1997), and the mouse c-myc coding region instability determinant binding protein (CRDBP) (Doyle et a…”
BackgroundYantiss, R. K., Woda, B. A., Fanger, G. R., Kalos, M., Whalen, G. F., Tada, H., Andersen, D. K., Rock, K. L., & Dresser, K. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000149688.98333.54 · Cited by 163
The Diverse Functions of IMP2/IGF2BP2 in Metabolism
Dai, N. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.05.007 · Cited by 114
Metadata
- Authors
- Doyle, G. A. R., Leeds, P. F., Fleisig, A. J., Ross, J., Betz, N. A., & Prokipcak, R. D.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-11-01
- Volume
- 26
- Issue
- 22
- Pages
- 5036-5044
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W1970766576
- Cited by
- 177
- References
- 3
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.